Indocyanine green: A novel marker for assessment of graft quality during ex situ normothermic machine perfusion of human livers
Artificial Organs · 2024-05 · 48 (5) · 472-483
DOI: 10.1111/aor.14696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 22.12.2023. Verfasst von Ngee-Soon Lau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Organ Assessment, Repair and Optimisation, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Indocyanine Green, Liver Transplantation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Ex situ machine perfusion facilitates the assessment of livers prior to transplantation. However, currently available markers of liver function poorly predict long‐term graft function. Indocyanine green (ICG) is a liver‐specific dye which, although common in vivo, has never been comprehensively evaluated for the assessment of graft quality during ex situ machine perfusion. This study aimed to assess the utility of ICG in the ex situ setting.
Methods
Using a customized long‐term perfusion system, human livers that were not suitable for transplantation were perfused using a red cell‐based perfusate. ICG was delivered into the perfusate on days 0, 1, and 4 to assess ICG clearance (spectrophotometric absorbance at 805 nm) and ICG fluorescence (near‐infrared camera).
Results
Sixteen partial livers were perfused for a median duration of 172 h (7.2 days). On day 0, the median ICG perfusate disappearance rate (PDR) was 7.5%/min and the median ICG retention at 15 min was 9.9%. Grafts that survived ≥7 days had a significantly higher median ICG PDR on day 0 (14.5%/min vs. 6.5%/min, p = 0.005) but not on days 1 or 4. ICG perfusion demonstrated that long‐surviving grafts had a significantly lower median red‐value (89.8 vs. 118.6, p = 0.011) and a significantly lower median blue‐value (12.9 vs. 22.6, p = 0.045) than short‐surviving grafts.
Conclusion
ICG is a novel marker for the assessment of liver function during ex situ normothermic machine perfusion. ICG PDR and quantitative ICG perfusion can distinguish between long‐ and short‐surviving grafts and demonstrate the utility of ICG in the assessment of graft quality prior to transplant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Organ Assessment, Repair and Optimisation, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Australian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Ngee-Soon Lau, Mark Ly, Ken Liu, Geoff McCaughan, Michael Crawford, Carlo Pulitano
Zitieren
APA
Lau, N. S., Ly, M., Ewenson, K., Toomath, S., Ly, H., Mestrovic, N., Liu, K., McCaughan, G., Crawford, M., & Pulitano, C. (2024). Indocyanine green: A novel marker for assessment of graft quality during ex situ normothermic machine perfusion of human livers. Artificial Organs, 48(5), 472-483. https://doi.org/10.1111/aor.14696
Vancouver
Lau NS, Ly M, Ewenson K, Toomath S, Ly H, Mestrovic N, et al. Indocyanine green: A novel marker for assessment of graft quality during ex situ normothermic machine perfusion of human livers. Artificial Organs. 2024;48(5):472-483. doi:10.1111/aor.14696
BibTeX
@article{Lau2024,
author = {Lau, Ngee-Soon and Ly, Mark and Ewenson, Kasper and Toomath, Shamus and Ly, Hayden and Mestrovic, Nicole and Liu, Ken and McCaughan, Geoff and Crawford, Michael and Pulitano, Carlo},
title = {Indocyanine green: A novel marker for assessment of graft quality during ex situ normothermic machine perfusion of human livers},
journal = {Artificial Organs},
year = {2024},
volume = {48},
number = {5},
pages = {472--483},
doi = {10.1111/aor.14696}
}
EUVIMED